ScinoPharm Taiwan Ltd
ScinoPharm Taiwan's GHG Emissions Data Preview
In 2023, ScinoPharm Taiwan completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, ScinoPharm Taiwan has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into ScinoPharm Taiwan's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of ScinoPharm Taiwan amounted to 21,360.51 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of ScinoPharm Taiwan increased by 10.63%, suggesting that the company faced challenges in reducing its emissions from its core operations.
ScinoPharm Taiwan's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are ScinoPharm Taiwan's Scope 1 emissions?
In 2023, the total Scope 1 emissions of ScinoPharm Taiwan were 4,292.54 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has ScinoPharm Taiwan reduced its Scope 1 emissions over time?
Since 2020, ScinoPharm Taiwan's Scope 1 emissions have increased by 61.5%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), ScinoPharm Taiwan's Scope 1 emissions increased by 31.56%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are ScinoPharm Taiwan's Scope 2 emissions?
In 2023, ScinoPharm Taiwan reported Scope 2 greenhouse gas (GHG) emissions of 17,067.97 tCOâ‚‚e without specifying the calculation method.
Has ScinoPharm Taiwan reduced its Scope 2 emissions over time?
Since 2020, ScinoPharm Taiwan's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 17.32%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), ScinoPharm Taiwan's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that ScinoPharm Taiwan 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does ScinoPharm Taiwan use for Scope 2 reporting?
In 2023, ScinoPharm Taiwan reported its Scope 2 emissions using an unspecified methodology.
ScinoPharm Taiwan's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)